Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMX2PJD)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Gedeptin; fludarabine phosphate; 75607-67-9; fludara; Fludarabine 5'-monophosphate; Fludura; Oforta; 2-Fluoro-ARA AMP; Fludarabine (phosphate); Fludarabine monophosphate; FAMP; UNII-1X9VK9O1SC; NSC-312887; C10H13FN5O7P; 2-Fluoro-9-(5-O-phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine; 2-Fluoroadenine arabinoside 5'-monophosphate; NSC 312887; NSC 328002; 1X9VK9O1SC; 9-beta-Arabinofuranosyl-2-fluoroadenine-5'-phosphate; Fludarabine Phosphate (Fludara); 9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-monophosphate; CHEBI:63599; 9-beta-D-Arab
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Breast
Breast adenocarcinoma
Breast epithelium
Normal
Cervix
Cervical adenocarcinoma
Colon
Colorectal adenocarcinoma
Kidney
Normal (Immortalized)
Normal (Transformed)
Liver
Hepatoblastoma
Lung
Lung adenocarcinoma
Non-small cell lung carcinoma
Pancreas
Pancreatic carcinoma
Peripheral blood
Acute monocytic leukemia
T-cell acute lymphoblastic leukemia
Prostate
Prostate carcinoma
Skin
Melanoma
Umbilical vein
Normal
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
